ArticleEsophagus : official journal of the Japan Esophageal Society2024

Second-line tislelizumab versus chemotherapy in Japanese patients with advanced or metastatic esophageal squamous cell carcinoma: subgroup analysis from RATIONALE-302.

Hiroki Hara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.